Cisiv
Satinderjit Sehra is a professional with a strong background in quality assurance and regulatory affairs within the pharmaceutical industry. With experience in various roles at companies such as Cisiv Ltd, Touchlight Genetics Ltd, and Baxter International Inc., Satinderjit has developed expertise in managing quality systems, implementing corrective action plans, and overseeing product development projects. They have a solid educational background with an MSc in Bioinformatics with Systems Biology and a BSc in Molecular Biology. Satinderjit is known for their attention to detail, ability to lead teams effectively, and commitment to maintaining compliance with industry regulations.
Cisiv
Cisiv’s technology platform is fit-for-purpose and enables Pharmaceutical and Medical Device companies to collect and manage safety and efficacy studies in the real world. Through our technology, organizations are able to expand their global reach and provide access to more patients. The platform, Baseline plus, spans every aspect of data collection and analysis as well as complex workflows for stakeholder engagement. This intuitive, modular web-based platform is highly configurable, providing unrivalled flexibility, no matter the scope or scale and has proven to reduce data management costs by 60%. Baseline Plus is an industry leading platform, including EDC, eConsent, ePRO, eCOA, eDiary, Surveys, Safety, e-Source, with functionality suitable for site-based, decentralized, and hybrid research. Currently, Cisiv’s intelligent platform is utilized by 90% of the top global pharmaceutical companies and has supported 200+ projects with pharma and biotech organizations.